| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61672-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11996-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-60733-0.1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21677-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22133-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-85467-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52681-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75910SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26685-50ul | |||
![Western Blot: CCR3 Antibody (8E9H10) [NBP2-61672] - Analysis using CD193 mAb against human CD193 (AA: extra mix) recombinant protein. (Expected MW is 37.2 kDa)](http://images.novusbio.com/fullsize/CCR3-Antibody-8E9H10-Western-Blot-NBP2-61672-img0003.jpg "Western Blot: CCR3 Antibody (8E9H10) [NBP2-61672] - Analysis using CD193 mAb against human CD193 (AA: extra mix) recombinant protein. (Expected MW is 37.2 kDa)")
![Flow Cytometry: CCR3 Antibody (8E9H10) [NBP2-61672] - Analysis of K562 cells using CCR3 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CCR3-Antibody-8E9H10-Flow-Cytometry-NBP2-61672-img0005.jpg)
![Western Blot: CCR3 Antibody (8E9H10) [NBP2-61672] - Analysis using CD193 mAb against HEK293 (1) and CD193 (AA: extra mix)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CCR3-Antibody-8E9H10-Western-Blot-NBP2-61672-img0004.jpg)
![Flow Cytometry: CCR3 Antibody (8E9H10) [NBP2-61672] - Analysis of HL-60 cells using CCR3 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CCR3-Antibody-8E9H10-Flow-Cytometry-NBP2-61672-img0002.jpg)
![ELISA: CCR3 Antibody (8E9H10) [NBP2-61672] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/CCR3-Antibody-8E9H10-ELISA-NBP2-61672-img0001.jpg)
![Western Blot: Neprilysin/CD10 Antibody (5E9A5) [NBP2-37301] - Western blot analysis using CD10 mAb against HEK293 (1) and CD10 (AA: 52-246)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-5E9A5-Western-Blot-NBP2-37301-img0003.jpg "Western Blot: Neprilysin/CD10 Antibody (5E9A5) [NBP2-37301] - Western blot analysis using CD10 mAb against HEK293 (1) and CD10 (AA: 52-246)-hIgGFc transfected HEK293 (2) cell lysate.")
![Immunohistochemistry: Neprilysin/CD10 Antibody (5E9A5) [NBP2-37301] - Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using CD10 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-5E9A5-Immunohistochemistry-NBP2-37301-img0004.jpg)
![Western Blot: Neprilysin/CD10 Antibody (5E9A5) [NBP2-37301] - Western blot analysis using CD10 mAb against human CD10 (AA: 52-246) recombinant protein. (Expected MW is 41.4 kDa)](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-5E9A5-Western-Blot-NBP2-37301-img0002.jpg)
![ELISA: Neprilysin/CD10 Antibody (5E9A5) [NBP2-37301] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/Neprilysin-CD10-Antibody-5E9A5-ELISA-NBP2-37301-img0001.jpg)
![Western Blot: CCR5 [p Ser337] Antibody (V14/2) - Chimeric [NBP3-11996] - K562 cell lysate (35ug protein in RIPA buffer) was resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of V14/2 (NBP3-11996) at 2ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.](http://images.novusbio.com/fullsize/CCR5-p-Ser337-Antibody-V14-2-Chimeric-Western-Blot-NBP3-11996-img0001.jpg "Western Blot: CCR5 [p Ser337] Antibody (V14/2) - Chimeric [NBP3-11996] - K562 cell lysate (35ug protein in RIPA buffer) was resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of V14/2 (NBP3-11996) at 2ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: CCR5 [p Ser337] Antibody (V14/2) - Chimeric [NBP3-11996] - Immunofluorescence analysis of paraformaldehyde fixed U937 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of V14/2 (NBP3-11996) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-11996, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CCR5-p-Ser337-Antibody-V14-2-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-11996-img0002.jpg)
![Flow Cytometry: CCR5 [p Ser337] Antibody (V14/2) - Chimeric - Azide and BSA Free [NBP3-11996] - U937 cells were fixed using 2% PFA and stained with anti-unknown specificity antibody (isotype control, black line) or NBP3-11996 (blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-11996_rabbit-monoclonal-ccr5-p-ser337-antibody-v14-2-chimeric-74202522113035.png)
![Immunohistochemistry-Paraffin: CD21 Antibody (CR2/1952) [NBP2-60732] - Formalin-fixed, paraffin-embedded human Follicular Dendritic Cell Sarcoma stained with CD21 Antibody (CR2/1952).](http://images.novusbio.com/fullsize/CD21-Antibody-CR2-1952-Immunohistochemistry-Paraffin-NBP2-60732-img0002.jpg "Immunohistochemistry-Paraffin: CD21 Antibody (CR2/1952) [NBP2-60732] - Formalin-fixed, paraffin-embedded human Follicular Dendritic Cell Sarcoma stained with CD21 Antibody (CR2/1952).")
![Immunohistochemistry-Paraffin: CD21 Antibody (CR2/1952) [NBP2-60732] - Formalin-fixed, paraffin-embedded Human Tonsil stained with CD21 Mouse Monoclonal Antibody (CR2/1952).](http://images.novusbio.com/fullsize/CD21-Antibody-CR2-1952-Immunohistochemistry-Paraffin-NBP2-60732-img0001.jpg)
![Protein Array: CD21 Antibody (CR2/1952) [NBP2-60732] - Analysis of Protein Array containing more than 19,000 full-length human proteins using CD21 Antibody (CR2/1952) Z- and S- Score: The Z-score represents the strength of a signal that a monoclonal antibody (MAb) (in combination with a fluorescently-tagged anti-IgG secondary antibody) produces when binding to a particular protein on the HuProt(TM) array. Z-scores are described in units of standard deviations (SD?s) above the mean value of all signals generated on that array. If targets on HuProt(TM) are arranged in descending order of the Z-score, the S-score is the difference (also in units of SD?s) between the Z-score. S-score therefore represents the relative target specificity of a MAb to its intended target. A MAb is considered to specific to its intended target, if the MAb has an S-score of at least 2.5.](http://images.novusbio.com/fullsize/CD21-Antibody-CR2-1952-Protein-Array-NBP2-60732-img0003.jpg)
![Immunohistochemistry: CD21 Antibody (7D6) [DDX0120P-100] - mAb 7D6 staining on FDC clusters. Slides were incubated with mAb 7D6 and subsequently with a sheep anti-mouse IgG1. The binding of antibody was revealed using APAAP method and developed by Fast red substrate.](http://images.novusbio.com/fullsize/CD21-Antibody-7D6-Immunohistochemistry-DDX0120P-100-img0002.jpg "Immunohistochemistry: CD21 Antibody (7D6) [DDX0120P-100] - mAb 7D6 staining on FDC clusters. Slides were incubated with mAb 7D6 and subsequently with a sheep anti-mouse IgG1. The binding of antibody was revealed using APAAP method and developed by Fast red substrate.")
![Immunohistochemistry: CD21 Antibody (7D6) [DDX0120P-100] - Giemsa staining of isolated FDCs clusters](http://images.novusbio.com/fullsize/CD21-Antibody-7D6-Immunohistochemistry-DDX0120P-100-img0001.jpg)
![Western Blot: CCR3 Antibody (SR2050) [NBP3-21677] - Western blot analysis using NBP3-21677 in K562 cell lysate.](http://images.novusbio.com/fullsize/nbp3-21677_rabbit-ccr3-mab-sr2050-57202315545126.jpg "Western Blot: CCR3 Antibody (SR2050) [NBP3-21677] - Western blot analysis using NBP3-21677 in K562 cell lysate.")
![Immunohistochemistry: CCR3 Antibody (SR2050) [NBP3-21677] - Immunohistochemical analysis of paraffin-embedded human epidemal cells of skin, using NBP3-21677.](http://images.novusbio.com/fullsize/nbp3-21677_rabbit-ccr3-mab-sr2050-5720231716189.jpg)
![Western Blot: ABCE1 Antibody (SR2116) [NBP3-22133] - Western blot analysis using NBP3-22133 in HeLa cell lysate.](http://images.novusbio.com/fullsize/nbp3-22133_rabbit-abce1-mab-sr2116-57202316494255.jpg "Western Blot: ABCE1 Antibody (SR2116) [NBP3-22133] - Western blot analysis using NBP3-22133 in HeLa cell lysate.")
![Immunohistochemistry: CCR10/GPR2 Antibody [NB100-707] - Paraffin section of human tonsil.](http://images.novusbio.com/fullsize/CCR10-GPR2-Antibody-Immunohistochemistry-NB100-707-img0004.jpg "Immunohistochemistry: CCR10/GPR2 Antibody [NB100-707] - Paraffin section of human tonsil.")
![Immunohistochemistry-Paraffin: CD55/DAF Antibody [NBP1-85467] - Immunohistochemistry analysis in human lung and pancreas tissues using NBP1-85467 antibody. Corresponding CD55 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CD55-DAF-Antibody-Immunohistochemistry-Paraffin-NBP1-85467-img0017.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD55/DAF Antibody [NBP1-85467] - Immunohistochemistry analysis in human lung and pancreas tissues using NBP1-85467 antibody. Corresponding CD55 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD55/DAF Antibody [NBP1-85467] - Staining of human placenta shows strong cytoplasmic positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/CD55-DAF-Antibody-Immunohistochemistry-Paraffin-NBP1-85467-img0016.jpg)
![Immunohistochemistry-Paraffin: CD55/DAF Antibody [NBP1-85467] - Staining of human lung shows strong cytoplasmic positivity in pneumocytes.](http://images.novusbio.com/fullsize/CD55-DAF-Antibody-Immunohistochemistry-Paraffin-NBP1-85467-img0015.jpg)
![Flow Cytometry: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Flow-cytometry using the anti-CD4 research biosimilar antibody Clenoliximab (NBP2-52681) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Clenoliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Chimeric-Flow-Cytometry-NBP2-52681-img0001.jpg "Flow Cytometry: CD4 Antibody (CE9.1 (Clenoliximab)) - Chimeric [NBP2-52681] - Flow-cytometry using the anti-CD4 research biosimilar antibody Clenoliximab (NBP2-52681) Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of Clenoliximab (panel B) at a concentration of 1 ug/ml for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow-cytometer.")
![Immunohistochemistry: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Anti-CD4 staining of formaldehyde fixed paraffin embedded guinea pig skin tissue, at 40x magnification. The human IgG4-chimeric version of CE9.1 (Clenoliximab) (NBP2-75910) was used to stain samples at a concentration of 3 ug/ml.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Immunohistochemistry-NBP2-75910-img0002.jpg "Immunohistochemistry: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Anti-CD4 staining of formaldehyde fixed paraffin embedded guinea pig skin tissue, at 40x magnification. The human IgG4-chimeric version of CE9.1 (Clenoliximab) (NBP2-75910) was used to stain samples at a concentration of 3 ug/ml.")
![Western Blot: CD4 Antibody (CE9.1 (Clenoliximab)) [NBP2-75910] - Human thyroid tumour samples were resolved on a 15% SDS PAGE gel and blots probed with the human IgG4-chimeric version of CE9.1 (NBP2-75910) at 1.5 ug/ml before detection using an anti-human IgG4 secondary antibody. Protein was detected by chemiluminescence. The expected unmodified running size for CD4 is 51kDa (arrowhead). Here some non-specific bands can also be seen. NBP2-75910 successfully detected CD4 in human thyroid tissue samples.](http://images.novusbio.com/fullsize/CD4-Antibody-CE9-1-Clenoliximab-Western-Blot-NBP2-75910-img0003.jpg)
![Immunoprecipitation: CCR9 Antibody (4G2) [NBP3-26685] - Immunoprecipitating CCR9 in HL-60 whole cell lysate. Lane 1: Rabbit control IgG instead of NBP3-26685 in HL-60 whole cell lysate. For western blotting, a HRP-conjugated Protein G antibody was used as the secondary antibody (1/2000). Lane 2: NBP3-26685 (3ug) + HL-60 whole cell lysate (500ug). Lane 3: HL-60 whole cell lysate (20ug).](http://images.novusbio.com/fullsize/nbp3-26685_rabbit-ccr9-mab-4g2-262202413221517.jpg "Immunoprecipitation: CCR9 Antibody (4G2) [NBP3-26685] - Immunoprecipitating CCR9 in HL-60 whole cell lysate. Lane 1: Rabbit control IgG instead of NBP3-26685 in HL-60 whole cell lysate. For western blotting, a HRP-conjugated Protein G antibody was used as the secondary antibody (1/2000). Lane 2: NBP3-26685 (3ug) + HL-60 whole cell lysate (500ug). Lane 3: HL-60 whole cell lysate (20ug).")
![Western Blot: CCR9 Antibody (4G2) [NBP3-26685] - Positive Western Blot detected in: SH-SY5Y whole cell lysate, HepG2 whole cell lysate, Jurkat whole cell lysate, HL-60 whole cell lysate, Hela whole cell lysate, U87 whole cell lysate, Mouse brain tissue. All lanes: CCR9 Antibody at 1ug/ml. Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 43, 41 KDa Observed band size: 43 KDa](http://images.novusbio.com/fullsize/nbp3-26685_rabbit-ccr9-mab-4g2-282202411472120.jpg)
![Immunocytochemistry/Immunofluorescence: CCR9 Antibody (4G2) [NBP3-26685] - Staining of HepG2 cells with CCR9 Antibody (4G2) at 1:33, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 488-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26685_rabbit-ccr9-mab-4g2-28220241312217.jpg)